Cancer

Our mission is to drive impactful innovation for cancer prevention, diagnosis, prognosis, treatment, and care through interdisciplinary research, fostering collaboration among researchers across disciplines within the Julius Center and beyond.

About us uitklapper, klik om te openen

Globally, about 10 million people died from cancer in 2020. With a 1 in 2 lifetime risk and 40% mortality rate in the Netherlands, cancer’s impact on people and society is profound. We initiate and contribute to high-quality applied cancer research to address these challenges, which requires health innovations for prevention, early detection, prognosis, treatment decisions, and supportive care.

The Julius Center Research Program Cancer includes researchers from various scientific disciplines: (clinical) epidemiology, biostatistics, data-science, health economic evaluation, bioethics, nursing science, primary care, and planetary health. We add value by combining our domain knowledge with expertise in state-of-the-art research methods, and closely work with health care providers, patients, and (translational) researchers from various disciplines within the UMC Utrecht, regionally, nationally, and internationally. We translate relevant oncological challenges into well-designed studies that answer impactful research questions with top-notch quantitative, qualitative, as well as mixed methods.

Specific topics of interest are prevention, early diagnosis, tailored treatment strategies, innovative trial design, nuclear diagnostics, prediction and monitoring, survivorship and lifestyle, palliation, and global oncology.

Coordinator and researchers uitklapper, klik om te openen

The head of the research program is Sjoerd Elias.
Principal investigators of the research program: Sjoerd Elias, Roel Vermeulen, Carla van Gils, Rieke van der Graaf, Marijke Kars, Anne May, Ewoud Schuit, Ewout Steyerberg, Saskia Teunissen and Peter van de Ven.